Chairperson
Patricia K. Coyle, MD has disclosed the following relationships:
Grant(s)/Research: Actelion, Novartis, and Opexa
Consultant Fee(s): AbbVie, Accordant, Acorda, Bayer, Biogen, Genentech/Roche, Genzyme/Sanofi, Mylan, Novartis, Serono, and Teva
Faculty
Fred D. Lublin, MD has disclosed the following relationships:
Grant(s)/Research: Acorda Therapeutics, Inc, Biogen Idec, Celgene, Genzyme
Novartis Pharmaceuticals Corp., Sanofi, Teva Neuroscience, Inc., and Transparency Live Sciences
Consultant Fee(s): Acorda Therapeutics, Inc., Actelion, Bayer HealthCare Pharmaceuticals, Biogen Idec, Bristol-Myers Squibb, Celgene, Coronad Bioscience, EMD Serono, Inc., Forward Pharma, Genentech, Genzyme, Johnson & Johnson, Medimmune, Novartis Pharmaceuticals Corp., Questocor, Receptos, Revalesio, Roche, Sanofi, Teva Neuroscience, Inc., and Xenoport
Stockholder: Cognition Pharmaceuticals, Inc.
Speakers' Bureau: Genzyme
Clyde E. Markowitz, MD has disclosed the following relationships:
Consultant Fee(s): Bayer, Biogen Idec, EMD Serono, Novartis, Genetech, Genzyme, Roche, Sanofi-Aventis, and Teva
Contracted Research: Genentech, Biogen Idec, EMD-Serono, Teva, Opexa, and Novartis
Aaron E. Miller, MD has disclosed the following relationships:
Grant(s)/Research: Biogen Idec, Genentech, Genzyme/Sanofi-Aventis, Novartis, Questocor, and Roche
Consultant Fee(s): Accordant Health Services, Acorda, Biogen Idec, EMD Serono, Inc., Genzyme/Sanofi-Aventis, Glaxo Smith Kline, Novartis, Questocor, Roche, and Teva
The following individuals have indicated no conflict of interest disclosures to report:
Michael O. Fleming, MD FAAFP (Course Director)
David Myland Kaufman, MD (Peer Reviewer)
Josh Kilbridge (Editor)
Matthew Fleming (Vice President, Antidote Education Company) UNAPPROVED PRODUCT USE
The faculty have indicated that this enduring material does not include discussion of the unlabeled/investigational use of a commercial product or device.
Albert Einstein College of Medicine, Antidote Education Company, Biogen Idec, Teva Pharmaceuticals, and Sanofi-Genzyme, a Sanofi company, do not recommend the use of any agent outside the labeled indications.
DISCLAIMER
The information presented in this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient’s medical condition.
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Albert Einstein College of Medicine, Montefiore Medical Center, Antidote Education Company, Biogen Idec, Teva Pharmaceuticals, and Sanofi-Genzyme, a Sanofi company. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
ACCREDITATION AND CREDIT DESIGNATION STATEMENTS
ACCME: Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Albert Einstein College of Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.